Executives On The Move: A Finance And Development Change At EyePoint Pharma And Exits At PPD And Novartis
Executive Summary
Ophthalmology biopharma EyePoint Pharmaceuticals confirms its new CFO and head of corporate development. A former PPD med director is now CMO of vaccine developer ILiAD Biotechnologies and neurological disorders firm Ovid Therapeutics adds ex-Novartis VP as chief commercial officer.